A major change in reimbursement was included in the fiscal year (FY) 2016 Medicare Hospice Proposed rule (CMS-1629-P), which was issued April 30 by the Centers for Medicare and Medicaid Services (CMS).
The Center for Medicare and Medicaid Services (CMS) released Part D Payment for Drugs for Beneficiaries Enrolled in Medicare Hospice, a notice that encourages sponsors to place beneficiary-level prior-authorization requirements on only 4 categories of prescription drugs identified in a June 2012 Office of Inspector General (OIG) Report:
The Centers for Medicare and Medicaid Services (CMS) is moving forward with the Medicare Care Choices Demonstration. This new model came out of the Affordable Care Act, and will allow Medicare beneficiaries in hospice to receive treatments aimed at helping them improve their medical condition at the same time that they receive palliative care, as well as end of life care.
The most recent installment in The Washington Post’s "Dying and Profits: The Evolution of Hospice" series summarizes a few key differences between noprofit and for-profit hospice providers.
A Jan. 14, 2015, Office of the Investigator General Report indicates that hospices have financial incentives to target Medicare beneficiaries that reside in assisted living who have certain diagnoses and are likely to have long stays.